- Home
- EPAC vs IRON Comparison
EPAC vs IRON Comparison
Compare EPAC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- IRON
- Stock Information
- Founded
- EPAC 1910
- IRON 2017
- Country
- EPAC United States
- IRON United States
- Employees
- EPAC N/A
- IRON N/A
- Industry
- EPAC Industrial Machinery/Components
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- EPAC Technology
- IRON Health Care
- Exchange
- EPAC Nasdaq
- IRON Nasdaq
- Market Cap
- EPAC 2.1B
- IRON 2.1B
- IPO Year
- EPAC N/A
- IRON N/A
- Fundamental
- Price
- EPAC $41.71
- IRON $84.99
- Analyst Decision
- EPAC Strong Buy
- IRON Strong Buy
- Analyst Count
- EPAC 2
- IRON 12
- Target Price
- EPAC $50.50
- IRON $103.33
- AVG Volume (30 Days)
- EPAC 353.9K
- IRON 613.1K
- Earning Date
- EPAC 10-15-2025
- IRON 11-07-2025
- Dividend Yield
- EPAC 0.10%
- IRON N/A
- EPS Growth
- EPAC 8.66
- IRON N/A
- EPS
- EPAC 1.70
- IRON N/A
- Revenue
- EPAC $616,899,000.00
- IRON N/A
- Revenue This Year
- EPAC $6.18
- IRON N/A
- Revenue Next Year
- EPAC $5.63
- IRON N/A
- P/E Ratio
- EPAC $24.54
- IRON N/A
- Revenue Growth
- EPAC 4.65
- IRON N/A
- 52 Week Low
- EPAC $36.51
- IRON $30.82
- 52 Week High
- EPAC $51.91
- IRON $95.95
- Technical
- Relative Strength Index (RSI)
- EPAC 52.86
- IRON 63.02
- Support Level
- EPAC $41.29
- IRON $83.95
- Resistance Level
- EPAC $42.48
- IRON $89.79
- Average True Range (ATR)
- EPAC 1.20
- IRON 3.83
- MACD
- EPAC 0.08
- IRON 0.10
- Stochastic Oscillator
- EPAC 48.27
- IRON 58.37
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.